These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 9764154)

  • 1. A randomized, double-blind study comparing the efficacy, safety and optimal dose of two formulations of cyclosporin, Neoral and Sandimmun, in patients with severe psoriasis. OLP302 Study Group.
    Koo J
    Br J Dermatol; 1998 Jul; 139(1):88-95. PubMed ID: 9764154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conversion of psoriasis patients from the conventional formulation of cyclosporin A to a new microemulsion formulation: a randomized, open, multicentre assessment of safety and tolerability.
    Zachariae H; Abrams B; Bleehen SS; Bräutigam M; Burrows D; Ettelt MJ; Fry L; Happle R; Haustein UF; Ganslandt J; Jung EG; Knop J; Kühne KH; Mellein B; Mørk NJ; Rogers S; Schmidt AG; Schopf RE; Sumner M; Taube KM; Weidinger G; Wurdel C; Zahn E
    Dermatology; 1998; 196(2):231-6. PubMed ID: 9568413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microemulsion formulation of cyclosporin (Sandimmun Neoral) vs Sandimmun: comparative safety, tolerability and efficacy in severe active rheumatoid arthritis. On behalf of the OLR 302 Study Group.
    Yocum DE; Allard S; Cohen SB; Emery P; Flipo RM; Goobar J; Jayawardena S; Job-Deslandre C; Jubb RW; Krüger K; Lopes Vaz A; Manger B; Mur E; Nygaard H; Weiner SM; Rainer F; Sack MR; Schiff MH; Schnitzer TJ; Trigg LB; Whatmough I; Schmidt AG
    Rheumatology (Oxford); 2000 Feb; 39(2):156-64. PubMed ID: 10725065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized trial of cyclosporine microemulsion (neoral) versus conventional cyclosporine in liver transplantation: MILTON study. Multicentre International Study in Liver Transplantation of Neoral.
    Otto MG; Mayer AD; Clavien PA; Cavallari A; Gunawardena KA; Mueller EA
    Transplantation; 1998 Dec; 66(12):1632-40. PubMed ID: 9884251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of diltiazem on concentration of cyclosporin metabolites in Sandimmune and Neoral treated kidney transplant patients].
    Sperschneider H; Wagner C; Korn A; Christians U
    Med Klin (Munich); 1997 Oct; 92(10):589-96. PubMed ID: 9446006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclosporine microemulsion increases drug exposure and reduces acute rejection without incremental toxicity in de novo renal transplantation. International Sandimmun Neoral Study Group.
    Keown P; Niese D
    Kidney Int; 1998 Sep; 54(3):938-44. PubMed ID: 9734620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The efficacy, tolerability and safety of a new oral formulation of Sandimmun--Sandimmun Neoral in severe refractory atopic dermatitis.
    Atakan N; Erdem C
    J Eur Acad Dermatol Venereol; 1998 Nov; 11(3):240-6. PubMed ID: 9883436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased bioavailability and improved efficacy, in severe psoriasis, of a new microemulsion formulation of cyclosporin.
    Gulliver WP; Murphy GF; Hannaford VA; Primmett DR
    Br J Dermatol; 1996 Sep; 135 Suppl 48():35-9. PubMed ID: 8881903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of cyclosporin A pharmacokinetics of a new microemulsion formulation and standard oral preparation in patients with psoriasis.
    Erkko P; Granlund H; Nuutinen M; Reitamo S
    Br J Dermatol; 1997 Jan; 136(1):82-8. PubMed ID: 9039300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and tolerability of a new oral formulation of cyclosporin A, Sandimmun Neoral, in renal transplant patients.
    Taesch S; Niese D
    Transpl Int; 1994; 7 Suppl 1():S263-6. PubMed ID: 11271220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized, double-blind, one-year study of the safety and tolerability of cyclosporine microemulsion compared with conventional cyclosporine in renal transplant patients. International Sandimmun Neoral Study Group.
    Frei UA; Neumayer HH; Buchholz B; Niese D; Mueller EA
    Transplantation; 1998 Jun; 65(11):1455-60. PubMed ID: 9645802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and pharmacokinetics of two formulations of cyclosporine A in patients with psoriasis.
    Elder CA; Moore M; Chang CT; Jin J; Charnick S; Nedelman J; Cohen A; Guzzo C; Lowe N; Simpson K
    J Clin Pharmacol; 1995 Sep; 35(9):865-75. PubMed ID: 8786246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Consistent absorption of cyclosporine from a microemulsion formulation assessed in stable renal transplant recipients over a one-year study period.
    Wahlberg J; Wilczek HE; Fauchald P; Nordal KP; Heaf JG; Olgaard K; Hansen JM; Lokkegaard H; Mueller EA; Kovarik JM
    Transplantation; 1995 Oct; 60(7):648-52. PubMed ID: 7570970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of two formulations of cyclosporin A in the treatment of severe atopic dermatitis. Aa double-blind, single-centre, cross-over pilot study.
    Zurbriggen B; Wüthrich B; Cachelin AB; Wili PB; Kägi MK
    Dermatology; 1999; 198(1):56-60. PubMed ID: 10026403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new microemulsion formulation of cyclosporin (Neoral) is effective in the treatment of cyclosporin-resistant dermatoses.
    Bourke JF; Berth-Jones J; Holder J; Graham-Brown RA
    Br J Dermatol; 1996 Apr; 134(4):777-9. PubMed ID: 8733391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Variability of the bioavailability of cyclosporine: benefit of the Neoral formulation].
    Humbert H
    Therapie; 1997; 52(4):353-7. PubMed ID: 9437891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and tolerability of conversion from stable Sandimmun maintenance treatment to Sandimmun Neoral in patients with rheumatoid arthritis.
    Flipo RM; Emery P; Scott DG; Situnayake RD; Prowse PJ; James DW; Cawley MI; Whatmough I; Schmidt AG
    J Rheumatol; 1998 Jul; 25(7):1263-9. PubMed ID: 9676754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neoral--new cyclosporin for old?
    Somerville MF; Scott DG
    Br J Rheumatol; 1997 Oct; 36(10):1113-5. PubMed ID: 9374930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the steady state pharmacokinetics of two formulations of cyclosporin in patients with atopic dermatitis.
    Chawla M; Ali M; Marks R
    Br J Dermatol; 1996 Sep; 135 Suppl 48():9-14. PubMed ID: 8881898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioavailability of Sandimmun® versus Sandimmun Neoral®: a meta-analysis of published studies.
    Colombo D; Egan CG
    Int J Immunopathol Pharmacol; 2010; 23(4):1177-83. PubMed ID: 21244766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.